{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T17:04:33Z","timestamp":1758992673052},"reference-count":0,"publisher":"OAE Publishing Inc.","content-domain":{"domain":["oaepublish.com"],"crossmark-restriction":false},"short-container-title":["CDR"],"DOI":"10.20517\/cdr.2019.09","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T03:08:50Z","timestamp":1551236930000},"update-policy":"http:\/\/dx.doi.org\/10.20517\/oae.crossmark.policy","source":"Crossref","is-referenced-by-count":2,"title":["Alkylating anticancer agents and their relations to microRNAs"],"prefix":"10.20517","author":[{"given":"Bernhard","family":"Biersack","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8410","published-online":{"date-parts":[[2019]]},"container-title":["Cancer Drug Resistance"],"original-title":[],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T08:42:43Z","timestamp":1705567363000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oaepublish.com\/articles\/cdr.2019.09"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":0,"URL":"https:\/\/doi.org\/10.20517\/cdr.2019.09","relation":{},"subject":[],"published":{"date-parts":[[2019]]}}}